Enliven Therapeutics Stock Forecast

Sell candidate since May 29, 2026 Loss -12.28%

The Enliven Therapeutics, Inc. stock price fell by -2.20% on the last day (Friday, 5th Jun 2026) from $35.49 to $34.71. During the last trading day the stock fluctuated 7.10% from a day low at $33.68 to a day high of $36.07. The price has fallen in 8 of the last 10 days and is down by -17.85% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -51 thousand shares and in total, 1 million shares were bought and sold for approximately $37.36 million.

Given the current short-term trend, the stock is expected to rise 22.73% during the next 3 months and, with a 90% probability hold a price between $42.60 and $65.60 at the end of this 3-month period.

ELVN Signals & Forecast

There are few to no technical positive signals at the moment. The Enliven Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $37.07 and $41.44. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, April 17, 2026, and so far it has fallen -27.85%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Enliven Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $31.15 and $30.05. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Enliven Therapeutics, Inc. finds support just below today's level at $31.15. If this is broken, then the next support from accumulated volume will be at $30.05 and $27.77.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.39 between high and low, or 7.10%. For the last week, the stock has had daily average volatility of 6.33%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ELVN) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Enliven Therapeutics, Inc. to open at $34.82, and during the day (based on 14 day Average True Range), to move between $33.63 and $35.79, which gives a possible trading interval of +/-$2.17 (+/-6.45%) up or down from last closing price. If Enliven Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 6.45% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $35.53 (2.36%) than the support at $31.15 (10.26%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Enliven Therapeutics, Inc. stock A Buy?

The Enliven Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Enliven Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -1.190 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $34.82 ( 0.317%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk